These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 6085754

  • 1. Metabolism of 9-beta-D-arabinosyl-2-fluoroadenine-5'-phosphate by mice bearing P388 leukemia.
    Avramis VI, Plunkett W.
    Cancer Drug Deliv; 1983; 1(1):1-10. PubMed ID: 6085754
    [Abstract] [Full Text] [Related]

  • 2. Pharmacodynamics and proposed mechanism of therapeutic action and host toxicity of 9-beta-D-arabinofuranosyl-2-fluoroadenine monophosphate (F-araAMP) in P388 murine leukemia-bearing mice.
    Avramis VI.
    Cancer Invest; 1989; 7(2):129-37. PubMed ID: 2477118
    [Abstract] [Full Text] [Related]

  • 3. 2-fluoro-ATP: a toxic metabolite of 9-beta-D-arabinosyl-2-fluoroadenine.
    Avramis VI, Plunkett W.
    Biochem Biophys Res Commun; 1983 May 31; 113(1):35-43. PubMed ID: 6860342
    [Abstract] [Full Text] [Related]

  • 4. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
    Avramis VI, Plunkett W.
    Cancer Res; 1982 Jul 31; 42(7):2587-91. PubMed ID: 7083151
    [Abstract] [Full Text] [Related]

  • 5. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs.
    Noker PE, Duncan GF, El Dareer SM, Hill DL.
    Cancer Treat Rep; 1983 May 31; 67(5):445-56. PubMed ID: 6189605
    [Abstract] [Full Text] [Related]

  • 6. 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphoma.
    Danhauser L, Plunkett W, Keating M, Cabanillas F.
    Cancer Chemother Pharmacol; 1986 May 31; 18(2):145-52. PubMed ID: 2431803
    [Abstract] [Full Text] [Related]

  • 7. Termination of DNA synthesis by 9-beta-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity.
    Huang P, Chubb S, Plunkett W.
    J Biol Chem; 1990 Sep 25; 265(27):16617-25. PubMed ID: 1697861
    [Abstract] [Full Text] [Related]

  • 8. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM, Rustum YM.
    Cancer Res; 1985 Dec 25; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [Abstract] [Full Text] [Related]

  • 9. Phosphorolytic cleavage of 2-fluoroadenine from 9-beta-D-arabinofuranosyl-2-fluoroadenine by Escherichia coli. A pathway for 2-fluoro-ATP production.
    Huang P, Plunkett W.
    Biochem Pharmacol; 1987 Sep 15; 36(18):2945-50. PubMed ID: 3307790
    [Abstract] [Full Text] [Related]

  • 10. Identification of metabolites of 9-beta-D-arabinofuranosyl-2-fluoroadenine, an antitumor and antiviral agent.
    Struck RF, Shortnacy AT, Kirk MC, Thorpe MC, Brockman RW, Hill DL, El Dareer SM, Montgomery JA.
    Biochem Pharmacol; 1982 Jun 01; 31(11):1975-8. PubMed ID: 7115418
    [Abstract] [Full Text] [Related]

  • 11. Interaction of arabinosyl nucleotides in K562 human leukemia cells.
    Gandhi V, Plunkett W.
    Biochem Pharmacol; 1989 Oct 15; 38(20):3551-8. PubMed ID: 2479383
    [Abstract] [Full Text] [Related]

  • 12. Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.
    Gandhi V, Plunkett W.
    Cancer Chemother Pharmacol; 1992 Oct 15; 31(1):11-7. PubMed ID: 1458554
    [Abstract] [Full Text] [Related]

  • 13. Primer RNA chain termination induced by 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-triphosphate. A mechanism of DNA synthesis inhibition.
    Catapano CV, Perrino FW, Fernandes DJ.
    J Biol Chem; 1993 Apr 05; 268(10):7179-85. PubMed ID: 7681821
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and biological evaluation of 9-[5'-(2-oxo-1,3,2-oxazaphosphorinan-2-yl)-beta-D-arabinosyl]ade nine and 9-[5'-(2-oxo-1,3,2-dioxaphosphorinan-2-yl)-beta-D-arabinosyl]ade nine: potential neutral precursors of 9-[beta-D-arabinofuranosyl]adenine 5'-monophosphate.
    Farquhar D, Smith R.
    J Med Chem; 1985 Sep 05; 28(9):1358-61. PubMed ID: 2411927
    [Abstract] [Full Text] [Related]

  • 15. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.
    Parker WB, Shaddix SC, Chang CH, White EL, Rose LM, Brockman RW, Shortnacy AT, Montgomery JA, Secrist JA, Bennett LL.
    Cancer Res; 1991 May 01; 51(9):2386-94. PubMed ID: 1707752
    [Abstract] [Full Text] [Related]

  • 16. The role of c-Jun kinase in the apoptotic response to nucleoside analogue-induced DNA damage.
    Sampath D, Plunkett W.
    Cancer Res; 2000 Nov 15; 60(22):6408-15. PubMed ID: 11103806
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of DNA synthesis in permeabilized mouse P815 mast cells by arabinofuranosyladenine 5'-triphosphate.
    Geurtsen W, Zahn RK, Maidhof A, Schmidseder R, Müller WE.
    Chemotherapy; 1981 Nov 15; 27(1):61-7. PubMed ID: 6163594
    [Abstract] [Full Text] [Related]

  • 18. Cellular and clinical pharmacology of fludarabine.
    Gandhi V, Plunkett W.
    Clin Pharmacokinet; 2002 Nov 15; 41(2):93-103. PubMed ID: 11888330
    [Abstract] [Full Text] [Related]

  • 19. Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine.
    Plunkett W, Benjamin RS, Keating MJ, Freireich EJ.
    Cancer Res; 1982 May 15; 42(5):2092-6. PubMed ID: 6175407
    [Abstract] [Full Text] [Related]

  • 20. A 3'-5' exonuclease in human leukemia cells: implications for resistance to 1-beta -D-arabinofuranosylcytosine and 9-beta -D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate.
    Skalski V, Brown KR, Choi BY, Lin ZY, Chen S.
    J Biol Chem; 2000 Aug 18; 275(33):25814-9. PubMed ID: 10833512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.